Search
Albuterol
go.drugbank.com/drugs/DB01001ApprovedInvestigationalVet approvedSalbutamol is formulated as a racemic mixture of the R- and S-isomers. … Salbutamol (Albuterol [USAN]) is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD.
Mixtures: ULAX-C, UNIBRON RCategories: Adrenergic beta-2 Receptor Agonists, Cytochrome P-450 CYP3A InhibitorsNacystelyn
go.drugbank.com/drugs/DB17839ExperimentalSynonyms: L-lysine, compd. with n-acetyl-l-cysteine, N-acetylcysteinate lysineCardiolipin Biosynthesis CL(a-13:0/a-13:0/a-13:0/a-13:0)
smpdb.ca/view/SMP0043663DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-13:0/a-25:0)
smpdb.ca/view/SMP0043667DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-15:0/a-15:0)
smpdb.ca/view/SMP0043682DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-15:0/a-17:0)
smpdb.ca/view/SMP0043683DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-17:0/a-13:0)
smpdb.ca/view/SMP0043698DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-17:0/a-21:0)
smpdb.ca/view/SMP0043701DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-21:0/a-17:0)
smpdb.ca/view/SMP0043718DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-21:0/a-25:0)
smpdb.ca/view/SMP0043720DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.